CIP
BEAT

Convergence Investment Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Convergence Investment Partners’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-57,788
Closed -$1.07M – 414
2016
Q3 		$1.07M Buy
+57,788
New +$1.09M 0.16% 229

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Convergence Investment Partners's BEAT Position: Q4 2016 in Review

Convergence Investment Partners sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 57,788 shares — an estimated $1.07M sold.

Convergence Investment Partners first reported a position in BEAT in Q3 2016 and held it in 1 quarter. The position peaked at $1.07M in Q3 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • Convergence Investment Partners reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
  • Convergence Investment Partners sold 57,788 BioTelemetry, Inc. shares in Q4 2016, an estimated $1.07M.
  • Convergence Investment Partners first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 1 quarter.
  • Convergence Investment Partners's BioTelemetry, Inc. position peaked at $1.07M in Q3 2016.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Convergence Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.